AAAAAA
Results:
1-10
|
Results: 10
Authors:
Holers, VM
Citation: Vm. Holers, Complement as a regulatory and effector pathway in human diseases, CONT IMMUN, 9, 2000, pp. 1-32
Authors:
Hack, CE
Citation: Ce. Hack, The regulation of C1 activation and its role in disease, CONT IMMUN, 9, 2000, pp. 33-56
Authors:
Narayana, SVL
Babu, YS
Valanakis, JE
Citation: Svl. Narayana et al., Inhibition of complement serine proteases as a therapeutic strategy, CONT IMMUN, 9, 2000, pp. 57-74
Authors:
Sahu, A
Morikis, D
Lambris, JD
Citation: A. Sahu et al., Complement inhibitors targeting C3, C4, and C5, CONT IMMUN, 9, 2000, pp. 75-112
Authors:
Wetsel, RA
Kildsgaard, J
Haviland, DL
Citation: Ra. Wetsel et al., Complement anaphylatoxins (C3a, C4a, C5a) and their receptors (C3aR, C5aR/CD88) as therapeutic targets in inflammation, CONT IMMUN, 9, 2000, pp. 113-153
Authors:
Quigg, RJ
Citation: Rj. Quigg, Modulation of disease using recombinant human endogenous complement inhibitors, CONT IMMUN, 9, 2000, pp. 155-170
Authors:
Xia, Y
Ross, GD
Citation: Y. Xia et Gd. Ross, Roles of integrins CR3 and CR4 in disease and therapeutic strategies, CONT IMMUN, 9, 2000, pp. 171-204
Authors:
Morgan, BP
Citation: Bp. Morgan, Inhibition of complement in the membrane attack pathway, CONT IMMUN, 9, 2000, pp. 205-224
Authors:
Giclas, PC
Citation: Pc. Giclas, Evaluation of complement inhibitors, CONT IMMUN, 9, 2000, pp. 225-236
Authors:
Ward, PA
Czermak, BJ
Huber-Lang, M
Diehl, K
Friedl, HP
Citation: Pa. Ward et al., Use of animal models to define complement functions, CONT IMMUN, 9, 2000, pp. 237-253
Risultati:
1-10
|